Poolbeg Pharma (LON:POLB) Hits New 52-Week Low – What’s Next?

Poolbeg Pharma PLC (LON:POLB)’s share price hit a new 52-week low on Wednesday . The stock traded as low as GBX 3 ($0.04) and last traded at GBX 3.01 ($0.04), with a volume of 869168 shares changing hands. The stock had previously closed at GBX 3.24 ($0.04).

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a “house stock” rating on shares of Poolbeg Pharma in a research report on Thursday, January 2nd.

Poolbeg Pharma Trading Up 3.2 %

The firm has a market capitalization of £16.45 million, a price-to-earnings ratio of 0.00 and a beta of 2.11. The stock has a fifty day moving average of GBX 4.82 and a 200-day moving average of GBX 7.47.

About Poolbeg Pharma

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.